Phase IIa study of fenretinide in superficial bladder cancer, using DNA flow cytometry as an intermediate end point
- PMID: 8271297
- DOI: 10.1093/jnci/86.2.138
Phase IIa study of fenretinide in superficial bladder cancer, using DNA flow cytometry as an intermediate end point
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
